Literature DB >> 15993715

IL-6 and IL-10 promoter gene polymorphisms of patients and donors of allogeneic sibling hematopoietic stem cell transplants associate with the risk of acute graft-versus-host disease.

Lidia Karabon1, Barbara Wysoczanska, Katarzyna Bogunia-Kubik, Krzysztof Suchnicki, Andrzej Lange.   

Abstract

The present study aimed to determine existing associations between single nucleotide polymorphisms within the promoters of interleukin (IL)-6 (-174 G/C) and IL-10 (-1082 G/A, -819 C/T, -592 C/A) genes and the outcome of allogeneic sibling hematopoietic stem cell transplantation. Ninety-three recipients and 74 donors were typed for IL-6 and IL-10 alleles by polymerase chain reaction-sequence specific primer. Then, IL-6 activity in patient serum and the concentration of C-reactive protein were analyzed at various times after transplantation in relation to transplant complications and IL-6 genotype. IL-6 activity in serum was significantly higher in patients who died as a result of toxic complications and after the 6 weeks after transplantation in patients with severe acute graft-versus-host disease (aGVHD). Recipient IL-6 G genotype was associated with increased IL-6 activity and C-reactive protein production. In univariate analyses, recipient IL-6 G and donor IL-6 GG associated or tended to associate with increased risk for aGVHD. In contrast, recipient IL-10 GCC/GCC and donor IL-10 ACC decreased the risk of aGVHD. IL-6 and IL-10 polymorphic features, together with other factors known to affect the risk of aGVHD, were also subjected to multivariate analyses. These analyses confirmed the independent contribution of recipient IL-10 GCC/GCC (odds ratio = 0.085, p = 0.046) and donor IL-6 GG (odds ratio = 3.934, p = 0.034) genotypes to the risk of aGVHD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15993715     DOI: 10.1016/j.humimm.2005.02.003

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  24 in total

Review 1.  Evaluation of published single nucleotide polymorphisms associated with acute GVHD.

Authors:  Jason W Chien; Xinyi Cindy Zhang; Wenhong Fan; Hongwei Wang; Lue Ping Zhao; Paul J Martin; Barry E Storer; Michael Boeckh; Edus H Warren; John A Hansen
Journal:  Blood       Date:  2012-01-26       Impact factor: 22.113

2.  Mapping of susceptibility and protective loci for acute GVHD in unrelated HLA-matched bone marrow transplantation donors and recipients using 155 microsatellite markers on chromosome 22.

Authors:  Tomoki Kikuchi; Taeko K Naruse; Makoto Onizuka; Suyun Li; Tetsuaki Kimura; Akira Oka; Yasuo Morishima; Jerzy K Kulski; Shingo Ichimiya; Noriyuki Sato; Hidetoshi Inoko
Journal:  Immunogenetics       Date:  2007-01-03       Impact factor: 2.846

Review 3.  Genomic and proteomic analysis of allogeneic hematopoietic cell transplant outcome. Seeking greater understanding the pathogenesis of GVHD and mortality.

Authors:  John A Hansen
Journal:  Biol Blood Marrow Transplant       Date:  2009-01       Impact factor: 5.742

4.  A pilot study of single nucleotide polymorphisms in the interleukin-6 receptor and their effects on pre- and post-transplant serum mediator level and outcome after allogeneic stem cell transplantation.

Authors:  T H A Tvedt; R Hovland; G Tsykunova; A B Ahmed; T Gedde-Dahl; Ø Bruserud
Journal:  Clin Exp Immunol       Date:  2018-04-01       Impact factor: 4.330

Review 5.  Genetics of allogeneic hematopoietic cell transplantation. Role of HLA matching, functional variation in immune response genes.

Authors:  John A Hansen; Effie W Petersdorf; Ming-Tseh Lin; Steven Wang; Jason W Chien; Barry Storer; Paul J Martin
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 6.  What are the most important donor and recipient factors affecting the outcome of related and unrelated allogeneic transplantation?

Authors:  Claudio Anasetti
Journal:  Best Pract Res Clin Haematol       Date:  2008-12       Impact factor: 3.020

Review 7.  Advances in predicting acute GVHD.

Authors:  Andrew C Harris; James L M Ferrara; John E Levine
Journal:  Br J Haematol       Date:  2012-12-04       Impact factor: 6.998

Review 8.  Effect of cytokine and pharmacogenomic genetic polymorphisms in transplantation.

Authors:  Diana M Girnita; Gilbert Burckart; Adriana Zeevi
Journal:  Curr Opin Immunol       Date:  2008-08-28       Impact factor: 7.486

9.  Prognostic value of pretransplant serum C-reactive protein in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation.

Authors:  Wataru Yamamoto; Eriko Fujii; Kenji Matsumoto; Eri Yamamoto; Jun Aoki; Masatsugu Tanaka; Yoshiaki Ishigatsubo; Heiwa Kanamori
Journal:  Int J Hematol       Date:  2016-01-20       Impact factor: 2.490

Review 10.  New advances in hematopoietic cell transplantation.

Authors:  Effie W Petersdorf; John A Hansen
Journal:  Curr Opin Hematol       Date:  2008-11       Impact factor: 3.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.